Canine Allergy Animation
Zoetis’ APOQUEL is the first medicine designed to target the itch and inflammation associated with canine allergic conditions such as flea allergy or contact allergy. It works by selectively inhibiting the pathways involved in sending itch signals to the brain, significantly reducing itching behaviour in affected dogs. It also blocks the signals involved in inflammation in the skin of the dog, resulting in decreased redness and itching.
We created a mechanism of action (MoA) animation showing the effects of APOQUEL on canine allergic itch and inflammation at a molecular level. This demonstrates how APOQUEL works differently to steroids, thus preventing the side effects associated with steroids and improving the quality of life of the affected dog.
The animation appears on the Zoetis APOQUEL product page, where it is used to educate animal health care providers about the benefits of treating canine allergic itch and inflammation with APOQUEL.
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.
‘‘For experts, there’s limited time in which they will interact with this content, so getting a message across quickly is crucial, and this medium does it very well.’’
Product Manager, GSK
‘‘Their turnaround time sets them apart from the rest of the field. The fact they can turnaround lots of comments in a couple of days is impressive, whereas that took weeks with other agencies we worked with. They’re well above the benchmark.’’
Oncology Clinical Liaison, Bristol-Myers Squibb
‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics
‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen